GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 38, Issue 11, Pages 2268-2277
Publisher
Springer Nature
Online
2013-05-17
DOI
10.1038/npp.2013.128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
- (2013) Xian-Cang Ma et al. PLoS One
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
- (2012) Hyo Jung Kang et al. NATURE MEDICINE
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- A pivotal role of GSK-3 in synaptic plasticity
- (2012) Clarrisa A. Bradley et al. Frontiers in Molecular Neuroscience
- Inhibition of GSK3 by lithium, from single molecules to signaling networks
- (2012) Laure Freland et al. Frontiers in Molecular Neuroscience
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
- (2011) Courtney S. Jernigan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- GSK-3: Functional Insights from Cell Biology and Animal Models
- (2011) Oksana Kaidanovich-Beilin et al. Frontiers in Molecular Neuroscience
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Long-term depression in the CNS
- (2010) Graham L. Collingridge et al. NATURE REVIEWS NEUROSCIENCE
- Novel Insights into Lithium’s Mechanism of Action: Neurotrophic and Neuroprotective Effects
- (2010) Jorge A. Quiroz et al. NEUROPSYCHOBIOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Dendritic spine formation and stabilization
- (2009) Yoshihiro Yoshihara et al. CURRENT OPINION IN NEUROBIOLOGY
- NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test
- (2009) M. Ghasemi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
- Treatment-resistant depression: recent developments and future directions
- (2008) Sanjay J. Mathew DEPRESSION AND ANXIETY
- What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies
- (2008) Abebaw Fekadu et al. JOURNAL OF AFFECTIVE DISORDERS
- Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: Role of corticosterone-mediated apical dendritic atrophy
- (2008) R.-J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of the protein p7OS6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain
- (2008) J DEGUIL et al. TOXICOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started